The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats
- PMID: 2573618
- DOI: 10.1016/0165-5728(89)90138-0
The beta-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats
Abstract
Treatment with the beta-adrenergic agonist isoproterenol suppresses clinical and histological experimental allergic encephalomyelitis in Lewis rats. The effect of isoproterenol treatment is greater when the drug is given from the time of immunization through the acute phase of the illness or from 8 to 14 days post-immunization than when given for the first 7 days after immunization.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
